Expertise in neurology, cerebrovascular disease, and the neurovascular-neurodegenerative interface, including the role of inflammation/infection, novel imaging measures, emerging therapeutic targets and clinical trials
Maggie's research is currently funded by the NHMRC and aims to develop cell and gene therapies and epigenetic biomarkers for repeat-associated neurodegenerative diseases. She has received Young Investigator Awards in Australia and the USA, and published in internationally recognized journals. A strong advocate for STEM research, Maggie communicates about science and its role in Australia’s health and economy via social and national media. In 2013, she received an Australian Leadership Award.
M.D., Ph.D. He has a deep knowledge of and experience in electrophysiology in monkeys (single neurons recordings) and humans (transcranial magnetic stimulation, study of spinal excitability and brain imaging). His current research include the study of the relationships between action and language and the realization of brain-computer interfaces specifically designed for human use.
Professor of Human Physiology, I'm a systems neuroscientist and neurologist by training. My current researches include the study of the cognitive aspects of motor control and the neural correlates of hierarchical learning in human and non-human primates. I'm also interested to multidimensional signal analysis and to the progress of neurotechnologies for developing innovative brain-computer interfaces.
Director of the Natural Substances, Traditional Medicine Section, Dept. of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità. Degree in Biology, specialty in Microbiology, University of Rome; postdoctoral training at Karolinska Institutet, Stockholm, Sweden. Current research on the bacterial CNF1 as a potential therapy for central nervous system (CNS) disorders. Co-inventor in 4 patents for CNF1 activity on the CNS, author of numerous articles in leading journals.
Assoc. Prof at Experimental and Regenerative Neurosciences, The University of Western Australia. Interested in secondary degeneration following neurotrauma, with particular focus on oxidative stress, oligodendrocyte precursor cells and structural changes to myelin. Therapeutic interventions currently being assessed include ion channel inhibitors, light therapy and targeted nanotechnologies.
National Health and Medical Research Council Research Fellow. Current research utilises modern neuroscientific techniques including Transcranial Magnetic Stimulation, Magnetic Resonance Imaging and Electroencephalography, to explore the neurobiology of pain perception and to develop novel treatment approaches for chronic pain syndromes.
1985-89 Res Assoc, INH Acad Sci GDR
1990-91 Head Lab "Hippocampal Slices",
1990-91 Res Ass., HHMI
1992-98 Head "Gene Regul & Plasticity", IfN
1998-2012 Head Dept. Neurophysiol IfN
2001- Prof Neurophysiol Med Fac Magdeburg
2006 Intern Acad Sci Health and Ecol
2008 Member of the Found Board of Dirs Dementia-Center Magdeburg
2013 Prof in Neurol and Charbonnier Prof BBDI USA
Prof in Human Physiol 1st Moscow State Med Univ
Presidium member Int Acad Sci Health & Ecol
Moores Professor of Vision Science, Biology and Optometry and Associate Dean Research/Graduate Studies in Physiological Optics and Vision Science, College of Optometry, University of Houston; Editor of the journal, Documenta Ophthalmologica; Fellow of the Association for Reserach in Vision and Ophthalmology (FARVO): Fellow of the American Academy of Optometry (FAAO); 2008 Glenn A. Fry Award for Research, American Optometric Foundation; 2006 Brian Boycott Retinal Research Award
Karl Friston is Professor of Imaging Neuroscience/Wellcome Principal Research Fellow, Faculty of Brain Science, University College London. In 2000 he was President of the international Organization of Human Brain Mapping. In 2003 he was awarded the Minerva Golden Brain Award and was elected a Fellow of the Royal Society in 2006. In 2008 he received a Medal, Collège de France and an Honorary Doctorate from the University of York in 2011. He became of Fellow of the Society of Biology in 2012.
Dorota Frydecka M.A., M.Sc. Eng., M.D. Ph.D. specialist in psychiatry
I am currently working as a psychiatrist, lecturer and researcher at the University Hospital in the Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland. Additionally, I work at the Department of Psychology as well as at the Institute of Health Psychology. My main interest is genetics, epigenetics psychoneuroimmunology and computational modeling of cognitive functions using artificial neural networks.
Professor in neuroscience, Head of Neuroscience department
INSERM Senior Group Leader of Cellular Therapies in Brain Diseases group